Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Michael Ryskin is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/03/2025 | MRVI | Buy Now | Maravai LifeSciences | $2.39 | 234.91% | Michael Ryskin46% | $9 → $8 | Maintains | Buy | Get Alert |
| 03/03/2025 | TEM | Buy Now | Tempus AI | $58.93 | 1.82% | Michael Ryskin46% | $54 → $60 | Maintains | Neutral | Get Alert |
| 02/04/2025 | IDXX | Buy Now | IDEXX Laboratories | $417.66 | 28.09% | Michael Ryskin46% | $475 → $535 | Maintains | Neutral | Get Alert |
| 12/13/2024 | TEM | Buy Now | Tempus AI | $58.93 | -8.37% | Michael Ryskin46% | $52 → $54 | Maintains | Neutral | Get Alert |
| 12/13/2024 | ALGN | Buy Now | Align Tech | $170.00 | 21.18% | Michael Ryskin46% | $200 → $206 | Maintains | Underperform | Get Alert |
| 10/02/2024 | TEM | Buy Now | Tempus AI | $58.93 | 1.82% | Michael Ryskin46% | $45 → $60 | Downgrade | Buy → Neutral | Get Alert |
| 07/18/2024 | GH | Buy Now | Guardant Health | $47.59 | -15.95% | Michael Ryskin46% | $28 → $40 | Maintains | Buy | Get Alert |
| 07/09/2024 | TEM | Buy Now | Tempus AI | $58.93 | -30.43% | Michael Ryskin46% | → $41 | Initiates | → Buy | Get Alert |
| 06/25/2024 | ALIT | Buy Now | Alight | $6.19 | 53.47% | Michael Ryskin46% | $10 → $9.5 | Maintains | Buy | Get Alert |
| 01/05/2024 | EXAI | Buy Now | Exscientia | — | — | Michael Ryskin46% | $11 → $9 | Downgrade | Buy → Neutral | Get Alert |
| 12/12/2023 | MRVI | Buy Now | Maravai LifeSciences | $2.39 | 234.91% | Michael Ryskin46% | $10 → $8 | Upgrade | Neutral → Buy | Get Alert |
| 08/15/2023 | CERT | Buy Now | Certara | $10.50 | 128.57% | Michael Ryskin46% | $27 → $24 | Maintains | Buy | Get Alert |
| 07/31/2023 | AVTR | Buy Now | Avantor | $16.35 | 46.79% | Michael Ryskin46% | $27 → $24 | Maintains | Buy | Get Alert |
| 06/16/2023 | ABCM | Buy Now | Abcam | — | — | Michael Ryskin46% | → $25 | Upgrade | Neutral → Buy | Get Alert |
| 04/30/2023 | AVTR | Buy Now | Avantor | $16.35 | 65.14% | Michael Ryskin46% | $30 → $27 | Maintains | Buy | Get Alert |
| 04/27/2023 | ALGN | Buy Now | Align Tech | $170.00 | 32.35% | Michael Ryskin46% | $190 → $225 | Maintains | Underperform | Get Alert |
| 11/04/2022 | ZTS | Buy Now | Zoetis | $161.30 | 11.59% | Michael Ryskin46% | $225 → $180 | Maintains | Buy | Get Alert |
| 11/03/2022 | MRVI | Buy Now | Maravai LifeSciences | $2.39 | 611.68% | Michael Ryskin46% | $32 → $17 | Downgrade | Buy → Neutral | Get Alert |
| 10/17/2022 | ALGN | Buy Now | Align Tech | $170.00 | 17.65% | Michael Ryskin46% | $235 → $200 | Maintains | Underperform | Get Alert |
| 08/10/2022 | OMIC | Buy Now | Singular Genomics Sys | — | — | Michael Ryskin46% | → $90 | Downgrade | Buy → Underperform | Get Alert |
| 07/28/2022 | ALGN | Buy Now | Align Tech | $170.00 | 38.24% | Michael Ryskin46% | $260 → $235 | Maintains | Underperform | Get Alert |
| 05/05/2022 | IDXX | Buy Now | IDEXX Laboratories | $417.66 | 12.53% | Michael Ryskin46% | $550 → $470 | Downgrade | Buy → Neutral | Get Alert |
| 04/18/2022 | RXRX | Buy Now | Recursion Pharmaceuticals | $6.55 | — | Michael Ryskin46% | — | Downgrade | Buy → Neutral | Get Alert |
| 02/16/2022 | ZTS | Buy Now | Zoetis | $161.30 | 57.47% | Michael Ryskin46% | $258 → $254 | Maintains | Buy | Get Alert |
| 02/03/2022 | ALGN | Buy Now | Align Tech | $170.00 | 194.12% | Michael Ryskin46% | $550 → $500 | Maintains | Underperform | Get Alert |
| 01/07/2022 | OMIC | Buy Now | Singular Genomics Sys | — | — | Michael Ryskin46% | → $630 | Upgrade | Neutral → Buy | Get Alert |
| 11/11/2021 | SDGR | Buy Now | Schrodinger | $21.35 | 143.55% | Michael Ryskin46% | $80 → $52 | Downgrade | Buy → Neutral | Get Alert |
| 11/10/2021 | ABSI | Buy Now | Absci | $3.11 | 221.54% | Michael Ryskin46% | $17 → $10 | Downgrade | Neutral → Underperform | Get Alert |
| 10/27/2021 | ZTS | Buy Now | Zoetis | $161.30 | 39.49% | Michael Ryskin46% | $225 → $225 | Maintains | Buy | Get Alert |
| 10/26/2021 | EXAI | Buy Now | Exscientia | — | — | Michael Ryskin46% | → $27 | Initiates | → Buy | Get Alert |
| 08/16/2021 | ABSI | Buy Now | Absci | $3.11 | 736.01% | Michael Ryskin46% | → $26 | Initiates | → Neutral | Get Alert |
| 07/27/2021 | ZTS | Buy Now | Zoetis | $161.30 | 39.49% | Michael Ryskin46% | → $225 | Maintains | Buy | Get Alert |
| 06/21/2021 | OMIC | Buy Now | Singular Genomics Sys | — | — | Michael Ryskin46% | → $780 | Initiates | → Neutral | Get Alert |
| 05/11/2021 | RXRX | Buy Now | Recursion Pharmaceuticals | $6.55 | 373.29% | Michael Ryskin46% | → $31 | Initiates | → Buy | Get Alert |
| 03/08/2021 | ZTS | Buy Now | Zoetis | $161.30 | 11.59% | Michael Ryskin46% | → $180 | Upgrade | Neutral → Buy | Get Alert |
| 01/05/2021 | CERT | Buy Now | Certara | $10.50 | 290.48% | Michael Ryskin46% | → $41 | Initiates | → Buy | Get Alert |
| 11/23/2020 | SDGR | Buy Now | Schrodinger | $21.35 | 246.59% | Michael Ryskin46% | → $74 | Upgrade | Neutral → Buy | Get Alert |
| 11/16/2020 | ABCM | Buy Now | Abcam | — | — | Michael Ryskin46% | → $20 | Initiates | → Neutral | Get Alert |
| 07/20/2020 | ZTS | Buy Now | Zoetis | $161.30 | -7.01% | Michael Ryskin46% | $135 → $150 | Maintains | Neutral | Get Alert |
| 07/20/2020 | ALGN | Buy Now | Align Tech | $170.00 | 64.71% | Michael Ryskin46% | → $280 | Downgrade | Neutral → Underperform | Get Alert |
| 05/14/2020 | SDC | Buy Now | SmileDirectClub | — | — | Michael Ryskin46% | $10 → $7 | Downgrade | Buy → Underperform | Get Alert |
| 02/26/2020 | SDC | Buy Now | SmileDirectClub | — | — | Michael Ryskin46% | $19 → $12 | Maintains | Buy | Get Alert |
| 02/12/2020 | ZTS | Buy Now | Zoetis | $161.30 | -10.11% | Michael Ryskin46% | $138 → $145 | Maintains | Neutral | Get Alert |
